High-precision testing of single cells with cutting-edge imaging
- Research
Tag: Research
Funding next generation of clinicians and researchers to save more Australian lives
The Leukaemia Foundation and Haematology Society of Australia and New Zealand (HSANZ) have again partnered to award three of Australia’s brightest blood cancer researchers and clinicians with PhD scholarships
- Media releases
- Research
Research news – August 2024
Chimeric antigen receptor (CAR) T-cell therapy is a revolutionary new type of treatment that ‘trains’ a patient’s own immune cells to seek out and kill cancer.
- Research
World Blood Cancer Day 2024
Discover more about the latest developments in stem cell transplants.
- bone marrow transplant
- Research
- Treatments and side-effects
Unlocking the Mysteries of Blood Cancer
In the ever-evolving landscape of blood cancer research, the quest to combat blood cancer continues to push boundaries. The New Directions in Leukaemia Research (NDLR) event in Adelaide last month brought together leading minds in the field to discuss breakthroughs, challenges, and the future of leukaemia treatment. From cutting-edge advancements in therapies to the promise of personalised medicine, the conference, sponsored by the Leukaemia Foundation, shed light on the latest discoveries and strategies shaping the fight against leukaemia.
- Research
Leukaemia Foundation calls for greater awareness of myeloma as incidence rates set to more than double by 2035
With myeloma incidence rates set to more than double by 2035, the Leukaemia Foundation is urgently calling for greater awareness and equitable access to treatment across the country, so myeloma patients have the best chance of survival, no matter where they live.
- Media releases
- Research
Replacing ‘blunt-edged’ chemotherapy with targeted treatment
To save more lives from AML, we urgently need to look past standard chemotherapy toward new, more effective approaches to treatment. Supported by Tour de Cure, one of our inaugural Breakthrough Fellowship recipients, Dr Ashwin Unnikrishnan, is doing just that.
- Research
Uncovering the secrets behind leukaemia treatment resistance
Acute lymphoblastic leukaemia (ALL) is a type of blood cancer, which sees the body produce dangerous numbers of immature white blood cells. Supported by Tour de Cure, one of our inaugural Breakthrough Fellowship recipients, Dr Ashley Ng, is leading advanced research to improve our understanding of treatment-resistant ALL and develop new ways of beating it.
- Research
Giles Purbrick was diagnosed with blood cancer, days after becoming a father
>In January 2020, Giles and wife Jacqui welcomed their baby daughter into the world. But just days later, Giles was hit with a shock blood cancer diagnosis that turned everything on its head.
- Lifestyle and living well
- Research
AML survivor Sophie Gray shares the role yoga and mindfulness played in her recovery
Sophie was diagnosed with AML in 2019, aged 29. She had a stem cell transplant later the same year from an unrelated donor and has been in remission ever since. After leaning on her yoga and mindfulness practice heavily through her recovery, Sophie underwent her yoga teacher training and teaches in Adelaide. In this article the Leukaemia Foundation asked Sophie some questions about her experience with complementary therapies.
- Lifestyle and living well
- Research
